CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-06 | BAKER BROS. ADVISORS LP Director | Other disposition | −200,423 | 98,980 | ||
| 2019-06-06 | BAKER BROS. ADVISORS LP Director | Other acquisition | +14,840 | 14,840 | ||
| 2019-06-06 | BAKER BROS. ADVISORS LP Director | Other acquisition | +14,840 | 14,840 | ||
| 2019-05-29 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +37,520 | 37,520 | ||
| 2019-05-29 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +37,520 | 37,520 | ||
| 2019-05-29 | Quart Barry D Director | Grant or award · Share Option | +18,760 | 18,760 | ||
| 2019-05-29 | Malley Thomas Director | Grant or award · Share Option | +18,760 | 18,760 | ||
| 2019-05-29 | McCain Tracey L Director | Grant or award · Share Option | +18,760 | 18,760 | ||
| 2019-05-29 | Popovits Kimberly J Director | Grant or award · Share Option | +18,760 | 18,760 | ||
| 2019-03-04 | Heberlig Chris EVP & CFO | Grant or award · Share Option | +46,000 | 46,000 | ||
| 2019-03-04 | Mahoney Stephen F. President & COO | Grant or award · Share Option | +83,000 | 83,000 | ||
| 2019-03-04 | Paolini John F. SVP & Chief Medical Officer | Grant or award · Share Option | +51,000 | 51,000 | ||
| 2019-03-04 | Patel Sanj K Chairman & CEO | Grant or award · Share Option | +187,000 | 187,000 | ||
| 2019-03-04 | Beetham Thomas W. EVP & Chief Legal Officer | Grant or award · Share Option | +42,000 | 42,000 | ||
| 2019-03-04 | Levy Richard S Director | Grant or award · Share Option | +37,965 | 37,965 | ||
| 2019-02-04 | BAKER BROS. ADVISORS LP Director | Grant or award · Class A1 Common Shares | +181,525 | 916,043 | ||
| 2019-02-04 | BAKER BROS. ADVISORS LP Director | Grant or award · Class A1 Common Shares | +1,818,475 | 8,837,349 | ||
| 2018-09-20 | Patel Sanj K Chairman & CEO | Grant or award · Share Option | +125,000 | 125,000 | ||
| 2018-09-20 | Paolini John F. SVP & Chief Medical Officer | Grant or award · Share Option | +45,000 | 45,000 | ||
| 2018-09-20 | Mahoney Stephen F. President & COO | Grant or award · Share Option | +50,000 | 50,000 |
Page 77 of 80 · 1,595 trades